Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Editor,—Cystoid macular oedema is a well known complication of chronic uveitis and is the major cause of visual disability accounting for 29% of blindness and 41% of visual impairment in this group.1
Therapy consists of control of inflammation with both topical and systemic agents. Symptomatic treatment with acetazolamide orally and grid laser photocoagulation have been shown to reduce cystoid macular oedema as well as vitrectomy.2 3
Treatment of cystoid macular oedema has been reported with good results by hyperbaric oxygen, but only limited follow up was presented.4-7
In 1986 a 46-year-old woman developed bilateral posterior uveitis with vitritis and periphlebitis of unknown origin. Routine uveitis screening disclosed no abnormalities. Despite locally administered drugs, high doses of systemic prednisolone, and acetazolamide cystoid macular oedema increased and persisted. Grid laser treatment …